New Information on Common Medications
- FRANKFURT (AP) — Medications containing promethazine will require updated product details following concerns raised by the European Pharmaceutical Agency regarding potential links to severe side effects.
- The agency's risk assessment committee has not ruled out causal relationships between promethazine and several life-threatening conditions.
- Promethazine is used to treat a variety of conditions, including allergic reactions, nausea, and vomiting.
Promethazine Drug Warnings Updated Over Serious Side Effect Concerns
Table of Contents
- Promethazine Drug Warnings Updated Over Serious Side Effect Concerns
- Promethazine Drug Warnings: Your Questions Answered
- What is Promethazine and What is it Used For?
- Why are Promethazine drug Warnings Being Updated?
- What are the Serious side Effects Associated with Promethazine?
- What Actions Have Been Taken Regarding Promethazine?
- What Changes Will Be Made to Promethazine Product Information?
- Where Can I Find a Summary of the Potential Risks?
- are There Any Groups of People Who Should Be Extra Cautious?
FRANKFURT (AP) — Medications containing promethazine will require updated product details following concerns raised by the European Pharmaceutical Agency regarding potential links to severe side effects.
The agency’s risk assessment committee has not ruled out causal relationships between promethazine and several life-threatening conditions.
Wide Use, Serious Risks
Promethazine is used to treat a variety of conditions, including allergic reactions, nausea, and vomiting. it is also prescribed to manage restlessness associated with psychiatric disorders and as a sleep aid for adults.
Potentially Life-Threatening Side effects
The risk assessment committee is concerned about potential links between promethazine and the following conditions:
- Neuroleptic Malignant Syndrome: A life-threatening reaction to antipsychotic medications.
- Torsade de Pointes: A perilous heart rhythm disorder.
- Thrombocytopenia: A deficiency in blood platelets.
- Potential for tissue damage, particularly with intravenous management.
EU Mandates Information Updates
The Coordination Group for Mutual Recognition and Decentralized Procedures (CMDH) issued a resolution in December 2024 mandating updates to product information for promethazine medications intended for systemic use (oral or intravenous). A similar action was taken regarding paracetamol last year.
The Federal Institute for Medicines and Medical Devices (bfarm) published a notice on April 15,2025,stating that without the agreed-upon changes,a positive benefit-risk relationship for systemic use of the affected medicines can no longer be assumed.
While promethazine medications will remain available, marketing authorization conditions will be modified based on CMDH recommendations. These changes will affect package inserts and specialist information to improve risk communication. Such warnings are not standard for approved drugs,but are more common on the pharmaceutical black market.
Specific Risks Highlighted
The CMDH also highlighted the possible occurrence of the following side effects, for which frequency could not be estimated based on available data:
- abnormal electrical activity in the heart, potentially leading to life-threatening rhythm disorders.
- Neuroleptic Malignant Syndrome: A severe reaction characterized by fever,muscle stiffness,changes in blood pressure,and coma.
- Low platelet count, increasing the risk of bleeding and bruising.
- Restlessness
- Hallucinations
- Aggressiveness
Patients are advised to consult with their doctors before taking promethazine, particularly if they have pre-existing heart conditions, a history of heart disease, or an irregular heartbeat.
Additional warnings regarding potential tissue injuries and QT interval prolongation will be added for intravenous administration. Caution is advised when promethazine is used concurrently with other medications.
Promethazine Drug Warnings: Your Questions Answered
Here’s what you need to know about the recent updates to promethazine warnings.
What is Promethazine and What is it Used For?
Promethazine is a medication used to treat several conditions. According to the provided information, it’s used for:
Allergic reactions
Nausea and vomiting
Restlessness associated with psychiatric disorders
As a sleep aid for adults
Why are Promethazine drug Warnings Being Updated?
Drug warnings for promethazine are being updated due to concerns raised by the European Pharmaceutical Agency regarding potential links to severe side effects. The agency’s risk assessment committee has identified possible causal relationships between promethazine and life-threatening conditions,prompting the need for updated product information.
What are the Serious side Effects Associated with Promethazine?
The risk assessment committee is concerned about potential links between promethazine and these conditions:
Neuroleptic Malignant Syndrome: A life-threatening reaction to antipsychotic medications.
Torsade de Pointes: A perilous heart rhythm disorder.
Thrombocytopenia: A deficiency in blood platelets.
Potential for tissue damage, notably with intravenous management.
What Actions Have Been Taken Regarding Promethazine?
The Coordination Group for Mutual Recognition and Decentralized Procedures (CMDH) issued a resolution in December 2024 mandating updates to product information for promethazine medications intended for systemic use (oral or intravenous). The Federal Institute for Medicines and Medical devices (BfArM) published a notice on April 15, 2025, stating that without the agreed-upon changes, a positive benefit-risk relationship for systemic use of the affected medicines can no longer be assumed.
What Changes Will Be Made to Promethazine Product Information?
Marketing authorization conditions will be modified based on CMDH recommendations. These changes will affect package inserts and specialist information to improve risk interaction. Additional warnings regarding potential tissue injuries and QT interval prolongation will be added for intravenous management.
Where Can I Find a Summary of the Potential Risks?
Here’s a summary of the specific risks highlighted by the CMDH:
| Side Effect | Description |
| ———————————— | ——————————————————————————————————————————————————————————- |
| Abnormal Electrical Activity in Heart | Can potentially lead to life-threatening rhythm disorders. |
| Neuroleptic Malignant Syndrome | A severe reaction characterized by fever, muscle stiffness, changes in blood pressure, and coma. |
| Low Platelet Count | Increases the risk of bleeding and bruising. |
| Restlessness | |
| Hallucinations | |
| Aggressiveness | |
| Tissue Injuries (IV administration) | Potential damage to tissue,particularly when administered intravenously. |
| QT Interval Prolongation (IV admin.) | A heart rhythm irregularity that can increase the risk of serious arrhythmias, especially in those with pre-existing heart conditions or taking other drugs with similar effects. |
are There Any Groups of People Who Should Be Extra Cautious?
Patients are advised to consult with thier doctors before taking promethazine, particularly if they have:
Pre-existing heart conditions
A history of heart disease
* An irregular heartbeat